Current role
Biotechnology · Healthcare
Board Member
2026-07-24–present
Charles Fuchs, M.D., M.P.H.
Board Member
CytomX Therapeutics, Inc. (CTMX)Equibles does not estimate personal net worth.
Get an email with a short summary when CytomX Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CTMX alertsAbout Charles Fuchs, M.D., M.P.H.
Charles Fuchs, M.D., M.P.H. is recorded as Board Member at CytomX Therapeutics, Inc. (CTMX) since July 24, 2026. CytomX Therapeutics, Inc. reported in an 8-K filed July 27, 2026 that Charles Fuchs, M.D., M.P.H. was appointed Class II director, effective July 24, 2026. CytomX Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CytomX Therapeutics, Inc. includes Sean McCarthy (CEO and Board Member), Chris Ogden (CFO and Chief Accounting Officer), Lloyd A. Rowland (General Counsel) and 7 others.
“On July 24, 2026, Charles Fuchs, M.D., M.P.H., was appointed to the Board of Directors (the "Board") of CytomX Therapeutics, Inc. (the "Company"), effective immediately, as a Class II director, with an initial term expiring at the Company's 2029 annual meeting of stockholders.”
Affiliation history
-
Current
2026-07-24–present
Company network
Leadership on record at CytomX Therapeutics, Inc.
- Sean McCarthy CEO, Board Member
- Chris Ogden CFO, Chief Accounting Officer
- Lloyd A. Rowland General Counsel
- Alan Ashworth Board Member
- Alan Ashworth, Ph.D., FRS Board Member
- Elaine V. Jones Board Member
- Elaine V. Jones Ph.D Board Member
- Elaine V. Jones Ph.D. Board Member
- Halley Gilbert Board Member
- James R. Meyers Board Member